Related Experiment Video
Updated: Aug 2, 2026
10:31
Lymphocyte Isolation from Human Skin for Phenotypic Analysis and Ex Vivo Cell Culture
Published on: April 8, 2016
Physiological studies with human leukocyte inhibitory factor
1National Jewish Center for Immunology and Respiratory Diseases, University of Colorado Health Sciences Center, Denver.
Immunology Series
|January 1, 1992
Summary
Leukemia inhibitory factor (LIF) activates neutrophil functions, enhancing their ability to combat pathogens. LIF promotes neutrophil migration and killing of targets, suggesting its therapeutic potential in inflammatory diseases.
Area of Science:
- Immunology
- Cell Biology
Background:
- Leukemia inhibitory factor (LIF) is recognized for its role in cell differentiation and proliferation.
- Neutrophils are critical immune cells involved in inflammatory responses and pathogen clearance.
Purpose of the Study:
- To investigate the specific effects of LIF on neutrophil function.
- To elucidate the mechanisms by which LIF modulates neutrophil activity.
Main Methods:
- Assessed LIF's impact on neutrophil chemotaxis and adherence.
- Measured expression and function of neutrophil receptors (fMLP, CR1, CR3, Fc gamma RIII).
- Evaluated LIF's effects on phagocytosis, respiratory burst, and degranulation.
Main Results:
- LIF exhibits dose-dependent effects on neutrophil chemotaxis, enhancing stimuli potency and promoting accumulation.
- LIF stimulates expression and function of key neutrophil receptors, including fMLP, CR1, CR3, and Fc gamma RIII.
- LIF significantly boosts neutrophil attachment, phagocytosis, respiratory burst activity, degranulation, and target cell killing.
Conclusions:
- LIF acts as a potent activator of neutrophil functions.
- LIF enhances neutrophil migration, adherence, and microbicidal activity through receptor-dependent and -independent pathways.
- LIF demonstrates significant potential as a therapeutic agent for inflammatory conditions and infections.
